What is CVE-2017-7917?

CVE-2017-7917 is a high-severity vulnerability in Moxa Oncell 5004-Hspa, classified under Cross-Site Request Forgery (CSRF). CVSS score: 8.8/10. Published 2017-05-29.

How severe is CVE-2017-7917?

High severity. CVSS v3 base score is 8.8 out of 10.

CSRF in Moxa Oncell 5004-Hspa

CVE-2017-7917

A Cross-Site Request Forgery issue was discovered in Moxa OnCell G3110-HSPA Version 1.3 build 15082117 and previous versions, OnCell G3110-HSDPA Version 1.2 Build 09123015 and previous versions, OnCell G3150-HSDPA Version 1.4 Build 11051315 and previous versions, OnCell 5104-HSDPA, OnCell 5104-HSPA, and OnCell 5004-HSPA. The application does not sufficiently verify if a request was intentionally provided by the user who submitted the request, which could allow an attacker to modify the configuration of the device.

Vulnerability class: CSRF (Cross-Site Request Forgery)

EPSS: 0.005 (39.6th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 8.8 (High). Vector: CVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H.

Affected products

Weakness classification (CWE)

CWE-352 — Cross-Site Request Forgery (CSRF)

References

ics-cert@hq.dhs.gov (US Government Resource, Third Party Advisory, x_refsource_MISC)

Frequently asked questions

What is CVE-2017-7917?: CVE-2017-7917 is a high-severity vulnerability in Moxa Oncell 5004-Hspa, classified under Cross-Site Request Forgery (CSRF). CVSS score: 8.8/10. Published 2017-05-29.
How severe is CVE-2017-7917?: High severity. CVSS v3 base score is 8.8 out of 10.